Caplacizumab-yhdp Ka pahu kui

Anter

• Ma mua o ka loaʻa ʻana o caplacizumab-yhdp,
• Hiki i Caplacizumab-yhdp ke hana i nā hopena ʻaoʻao. E haʻi i kāu kauka inā koʻikoʻi kekahi o kēia mau ʻōuli a mai hele aku paha:
• Hiki i kekahi o nā hopena ʻaoʻao ke koʻikoʻi. Inā ʻike ʻoe i kekahi o kēia mau ʻōuli e kāhea koke i kāu kauka a i ʻole e loaʻa i ka lāʻau lapaʻau olakino.
• Pākuʻi ʻia paha nā ʻōuli o ka overdose:

Hoʻohana ʻia ka injection Caplacizumab-yhdp e mālama i ka thrombotic thrombositopenic purpura (aTTP; kahi maʻi kahi e hoʻouka ai ke kino iā ia iho a kumu i nā clots, nā liʻiliʻi o nā platelet a me nā ʻulaʻula o ke koko, a hiki ke hana i nā pilikia koʻikoʻi ʻē aʻe) i hui pū ʻia me ka lāʻau exchange exchange plasma a lāʻau hoʻomalu pale pale. Aia ʻo Caplacizumab-yhdp i kahi papa o nā lāʻau i kapa ʻia nā agith antithrombotic. Hana ia ma ke kāpae ʻana i ka hana o kekahi mea i ke kino i kumu i nā ʻōuli o aTTP.

Hele mai ʻo Caplacizumab-yhdp me he pauka e hoʻoheheʻe ʻia i loko o ka wai a hāʻawi ʻia e ka intravenous (i loko o ke aa) a i ʻole subcutaneile (ma lalo o ka ʻili) ʻoki. Hāʻawi pinepine ʻia ia i ka lā mua o ka mālama ʻana ma ke ʻano he inikōni intravenous ma ka liʻiliʻi he 15 mau minuke ma mua o ka pānaʻi ʻana o ka plasma, a laila ma ke ʻano he inikō subcutaneite ma hope o ka pau ʻana o ka pānaʻi plasma. Ma hope o ka lā mua o ka hoʻomaʻamaʻa hāʻawi pinepine ʻia ia ma ke ʻano he inika subcutaneus i kēlā me kēia lā ma hope o ka pānaʻi plasma no ka mea ke loaʻa iā ʻoe kahi pānaʻi pānaʻi plasma, a laila hoʻokahi manawa i kēlā me kēia lā no kahi 30 hou aʻe i 58 mau lā ma hope o ka hoʻōki ʻana i ka lāʻau pānaʻi plasma E hoʻohana i ka caplacizumab-yhdp ma kahi o ka manawa like i kēlā me kēia lā. E hāhai pono i nā ʻōkuhi i kāu lepili kuhikuhi, a nīnau i kāu kauka a kauka paha e wehewehe i kahi ʻāpana āu i maopopo ʻole ai. E hoʻohana pono iā caplacizumab-yhdp e like me ke kuhikuhi. Mai hoʻohana i ka ʻoi aku a i ʻole ka liʻiliʻi o ia mea a hoʻohana pinepine paha iā ia ma mua o ka mea i kauoha ʻia e kāu kauka.

ʻAe paha kāu kauka iā ʻoe a i kahi mea mālama paha e hana i nā injection i ka home. E noi i kāu kauka a kauka paha e hōʻike iā ʻoe a i ʻole i ke kanaka e hana ana i nā injection inā pehea e hoʻomākaukau ai a hoʻokomo iā caplacizumab-yhdp. Ma mua o kou hoʻohana ʻana iā caplacizumab-yhdp injection iā ʻoe iho no ka manawa mua, e heluhelu i nā ʻōkuhi i kākau ʻia me ia. E noi i kāu kauka lāʻau a kauka paha no kahi kope o nā ʻōlelo a ka mea hana no ka hoʻohana ʻana i ka ʻike no ka mea maʻi.

Pono ʻoe e hoʻopili i ka caplacizumab-yhdp injection subcutaneously i loko o ka ʻōpū (ʻōpū) akā e hōʻalo i kou piko a me kahi ʻelua ʻīniha (5 centimita) a puni ia. Mai hoʻokomo i ka wahi like i ʻelua mau lā ma ka lālani.

E hoʻolei i nā nila, nā ʻeneka, a me nā ipu i loko o kahi pahu kūpaʻa. E kamaʻilio me kāu kauka a kauka paha e pili ana i ka hoʻolei ʻana i ka ipu kūpaʻa.

Kau ʻia kēia lāʻau no nā hoʻohana ʻē aʻe; e noi i kāu kauka a kauka paha no ka ʻike hou aku.

Ma mua o ka loaʻa ʻana o caplacizumab-yhdp,

• e haʻi i kāu kauka a me ka kauka inā he maʻi ʻoe i ka caplacizumab-yhdp, nā lāʻau ʻē aʻe, a i ʻole kekahi o nā mea hana i ka injection caplacizumab-yhdp E noi i kāu kauka lāʻau no kahi papa inoa o nā mea hoʻohui.
• e haʻi i kāu kauka a me ka mea kauka lāʻau he aha nā lāʻau lapaʻau a me nā lāʻau ʻole i kuhikuhi ʻia, nā wikamina, nā mea hoʻopihaʻai, a me nā huahana lāʻau āu e lawe nei a hoʻolālā paha e lawe E hōʻike pono i kekahi o kēia mau mea: apixaban (Eliquis), clopidogrel (Plavix), dabigatran (Pradaxa), dipyrimadole (Persantine, ma Aggrenox), edoxaban (Savaysa), enoxaparin (Lovenox), fondaparinux (Arixtra), heparin, prasugrel (Pono), rivaroxaban (Xarelto), ticagrelor (Brilinta), a i ʻole warfarin (Coumadin, Jantoven). Pono paha kāu kauka e hoʻololi i nā kaha o kāu mau lāʻau a nānā pono iā ʻoe no nā hopena ʻaoʻao.
• e haʻi i kāu kauka inā loaʻa iā ʻoe a i ʻole he hemophilia paha (kahi maʻi genetical kahi i hiki ʻole ai i ke kino ke hoʻopau pono i ke kahe ʻana) a i ʻole nā ​​pilikia kahe koko, a i ʻole nā ​​maʻi ate.
• e haʻi i kāu kauka inā hāpai ʻoe, hoʻolālā e hāpai, a i ʻole e hānai umauma ana. Inā hāpai ʻoe i ka loaʻa ʻana o caplacizumab-yhdp, e kāhea i kāu kauka.
• inā ke ʻoki nei ʻoe, e like me ke kaha ʻana o ka niho, e haʻi i ke kauka a i ʻole kauka niho paha e hoʻohana nei ʻoe i ka caplacizumab-yhdp. E haʻi paha kāu kauka a kauka niho paha iā ʻoe ʻaʻole e hoʻohana i ka caplacizumab-yhdp no 7 mau lā ma mua o ke kaha ʻana.

Inā ʻaʻole haʻi kāu kauka iā ʻoe, e hoʻomau i kāu papaʻai maʻamau.

E hoʻohana i ka lāʻau i hala i kou wā e hoʻomanaʻo ai. Eia nō naʻe, inā ʻaʻole ʻoe e loaʻa hou i ka lāʻau pānaʻi plasma exchange, a ʻoi aku ma mua o 12 mau hola i hala ma hope o ka hala ʻana o ka lāʻau, haʻalele i ka lāʻau i hala a hoʻomau i kāu papa hana maʻamau. Mai hoʻohana i kahi lāʻau pālua e pani no kahi mea i hala.

Hiki i Caplacizumab-yhdp ke hana i nā hopena ʻaoʻao. E haʻi i kāu kauka inā koʻikoʻi kekahi o kēia mau ʻōuli a mai hele aku paha:

• ʻeha poʻo
• luhi loa
• ʻeha kua
• ʻeha mākala
• ʻalalā, ʻūlū ʻana, a i ʻole ʻano ʻūnana i ka ʻili
• ʻume ma kahi kokoke i kahi o ka lāʻau i injected
• pokole o ka hanu
• fiva

Hiki i kekahi o nā hopena ʻaoʻao ke koʻikoʻi. Inā ʻike ʻoe i kekahi o kēia mau ʻōuli e kāhea koke i kāu kauka a i ʻole e loaʻa i ka lāʻau lapaʻau olakino.

• hives
• kahe nui ʻana o ke kahe e kū ʻole me ke kahe ʻana o ke kōkō, ka maʻi ʻōpū, ka ihu, nā kāʻei a i ʻole ka wahi i ʻami ʻia ai ka lāʻau
• luaʻi koko
• ʻulaʻula, a ʻeleʻele, noho aliʻi
• koko i ka mimi
• hōʻeha kūpikipiki loa, kahoʻi, luaʻi
• ʻāwīwī, ʻeha ka ʻōpū o ka ʻōpū, nausea, luaʻi
• pinepine, ʻeha, a i ʻole ka mimiki wikiwiki

Hoʻokumu paha ka injection Caplacizumab-yhdp i nā hopena ʻē aʻe. Kāhea i kāu kauka inā he pilikia ʻokoʻa kāu i ka lawe ʻana i kēia lāʻau.

Inā ʻoe e ʻike i kahi hopena koʻikoʻi, e hoʻouna ʻoe a i ʻole kāu kauka i kahi hōʻike i ka papahana hōʻike ʻino a MedWatch Adverse Event Food (FDA) ma ka pūnaewele (http://www.fda.gov/Safety/MedWatch) a i ʻole kelepona. 1-800-332-1088).

E mālama i kēia lāʻau i loko o ka pahu i komo ai, pani paʻa ʻia, a ʻaʻole hiki i nā kamaliʻi. E mālama iā ia i loko o ka pahu hau, a haʻalele i ke kukui. Mai paʻa hau. Hiki ke mālama ʻia ka pahu kui Caplacizumab-yhdp ma ke ana wela no 2 mau mahina akā e mālama ʻia ma ka pahu kumu e pale ai i ka mālamalama. ʻAʻole pono e hoʻihoʻi ʻia ʻo Caplacizumab-yhdp i loko o ka pahu hau ma hope o ka mālama ʻia ʻana i ke ana wela o ka lumi.

He mea nui e mālama i nā lāʻau āpau mai ka maka a hiki i nā keiki e like me nā ipu (e like me nā minder pill i kēlā me kēia pule a me nā mea no nā kulu maka, nā kalima, nā pākuʻi, a me nā inhalers) ʻaʻole pale keiki a hiki i nā keiki ʻōpio ke wehe maʻalahi iā lākou. No ka pale ʻana i nā keiki ʻōpio mai ka lāʻau make, laka mau i nā pāpale palekana a kau koke i ka lāʻau i kahi palekana - kahi i luna a mamao a mai ko lākou alo a hiki. http://www.upandaway.org

Pono e hoʻolei ʻia nā lāʻau i koi ʻole ʻia i nā ala kūikawā e hōʻoia i ka hiki ʻole i nā holoholona, ​​nā keiki, a me nā poʻe ʻē aʻe ke hoʻopau iā lākou. Eia nō naʻe, ʻaʻole pono ʻoe e kaomi i kēia lāʻau i ka lua. Akā, ʻo ke ala ʻoi loa e hoʻolilo i kāu lāʻau i loko o kahi papahana hoʻihoʻi lāʻau. E kamaʻilio me kāu kauka lāʻau a kāhea paha i kāu ʻōpala a me nā hana hoʻopōʻaiapuni kūloko e aʻo e pili ana i nā papahana hoʻihoʻi i kou kaiāulu. E ʻike i ka pūnaewele palekana o kā FDA's Disposal of Medicines (http://goo.gl/c4Rm4p) no ka ʻike hou aku inā ʻaʻohe ou komo i kahi papahana hoʻihoʻi.

I ke kumu o ka overdose, e kāhea i ka helpline kaohi lāʻau make ma 1-800-222-1222. Loaʻa ka ʻike ma ka pūnaewele ma https://www.poisonhelp.org/help. Inā ua hina ka mea i hoʻomāinoino ʻia, loaʻa ka hopu ʻana, pilikia i ka hanu ʻana, a i ʻole hiki ʻole ke ala aʻe, e kāhea koke i nā lawelawe kūikawā ma 911.

Pākuʻi ʻia paha nā ʻōuli o ka overdose:

• kahe ana ke koko

E mālama i nā manawa a pau me kāu kauka a me ka hale hana. E kauoha ke kauka i kekahi mau hoʻokolohua lab e nānā inā e hoʻomau ʻia ka mālama ʻana me caplacizumab-yhdp.

Mai ʻae i kekahi e hoʻohana i kāu lāʻau. E nīnau i kāu kauka lāʻau i nā nīnau āu e pili ana i ka hoʻopiha hou ʻana i kāu kuhikuhi.

He mea nui iā ʻoe e mālama i kahi papa inoa i kākau ʻia a me nā lāʻau lapaʻau ʻole (over-the-counter) lāʻau āu e lawe nei, a me nā huahana e like me nā huaora, nā minelala, a i ʻole nā ​​mea hoʻopiliʻai aʻe.Pono ʻoe e lawe i kēia papa inoa me ʻoe i kēlā me kēia manawa ke kipa ʻoe i ke kauka a i ʻole inā ʻae ʻia ʻoe i kahi haukapila. He ʻike nui nō hoʻi ia e lawe pū me ʻoe inā pilikia ʻo ka pilikia.

• ʻO Cablivi^®